Abstract:Background The role of tumour-associated macrophages (TAMs) in predicting the prognosis of colorectal cancer (CRC) remains controversial. This is especially so because the prognostic significance and clinicopathological relevance of different subtypes of TAMs in the immune microenvironment of CRC have not yet been established. Objective To assess the clinicopathological and prognostic value of pan-macrophages, M1-macrophages or M2-macrophages in patients with CRC. Methods Comprehensive searched on the Medline/PubMed, Web of Science (WoS) and Google Scholar databases was conducted to identify relevant studies published up to April 2019. The association between overall survival (OS), cancer-specific survival (CSS) or disease-free survival (DFS) and TAMs was analysed by meta-analysis. Results A total of 3749 patients from 17 studies were included. The pooled hazard ratios (HRs) indicated that high-density pan-macrophages improved OS (HR 0.67, P = 0.02). The pooled HR for M2-macrophages showed that high M2-macrophages infiltration was significantly associated with shorter OS (HR 2.93, P < 0.0001) and DFS (HR 2.04, P = 0.02). The pooled odds ratios (ORs) revealed that high-density TAMs was associated with high CD8+ T cell infiltration (OR 2.04, P = 0.007), no distant metastasis (NDM) (OR 0.38, P < 0.0001), microsatellite instability-high (MSI-H) (OR 0.38, P = 0.001), no lymph node metastasis (NLNM) (OR 0.54, P = 0.0002) and non-mucinous cancer (OR 0.39, P < 0.00001). Conclusions Unlike other solid tumours, high-density CD68+ macrophage infiltration can be a good prognostic marker for CRC. However, when macrophages act as targets of combination therapy in CRC treatment, this might be more effective for CRC patients with high CD8+ T cell infiltrate, NDM, MSI-H, NLNM and non-mucinous cancer.

Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis

Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis

Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer

Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives

[Research Progress on Tumor-Associated Macrophages in Colorectal Cancer].

Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications

Decoding the spatiotemporal heterogeneity of tumor-associated macrophages

Tumor associated macrophages (TAMs): from mechanisms to therapeutic implications

Tumor-associated macrophages: Potential therapeutic targets and diagnostic markers in cancer

Tumor-Associated Macrophages in Tumor Immunity

Tumor-Associated Macrophages: A Potential Target For Cancer Therapy

Role of Tumor-Associated Macrophages in Common Digestive System Malignant Tumors

Tumor-associated Macrophages in Lung Carcinoma: from Mechanism to Therapy.

Natural compounds modulate the mechanism of action of tumour-associated macrophages against colorectal cancer: a review

Research Progress on the Role of Tumor‑associated Macrophages in Tumor Development and Their Use As Molecular Targets (Review).

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

Exploring the Tumor Promoting Role of Anti-Tumor Macrophage: a Developmental Perspective

Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies

Modulation of tumor-associated macrophages in colitis-associated colorectal cancer.